{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T08:41:35Z","timestamp":1765356095250},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2-3","license":[{"start":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T00:00:00Z","timestamp":1473984000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Funct Integr Genomics"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s10142-016-0520-1","type":"journal-article","created":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T07:41:54Z","timestamp":1474011714000},"page":"263-277","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Regulatory network analysis of microRNAs and genes in imatinib-resistant chronic myeloid leukemia"],"prefix":"10.1007","volume":"17","author":[{"given":"Ismael","family":"Soltani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanen","family":"Gharbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Islem Ben","family":"Hassine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghada","family":"Bouguerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kais","family":"Douzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mouheb","family":"Teber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salem","family":"Abbes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samia","family":"Menif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,16]]},"reference":[{"key":"520_CR1","doi-asserted-by":"publisher","unstructured":"A J, Qian S, Wang G, Yan B, Zhang S, Huang Q, Ni L, Zha W, Liu L, Cao B, Hong M, Wu H, Lu H, Shi J, Li M, Li J (2010) Chronic myeloid leukemia patients sensitive and resistant to imatinib treatment show different metabolic responses. PLoS One 5:e13186. DOI 10.1371\/journal.pone.0013186","DOI":"10.1371\/journal.pone.0013186"},{"key":"520_CR2","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/ajh.22272","volume":"87","author":"M Alikian","year":"2012","unstructured":"Alikian M, Gerrard G, Subramanian PG, Mudge K, Foskett P, Khorashad JS, Lim AC, Marin D, Milojkovic D, Reid A, Rezvani K, Goldman J, Apperley J, Foroni L (2012) BCR-ABL1 kinase domain mutations: methodology and clinical evaluation. Am J Hematol 87:298\u2013304. doi: 10.1002\/ajh.22272","journal-title":"Am J Hematol"},{"key":"520_CR3","doi-asserted-by":"publisher","first-page":"e78582","DOI":"10.1371\/journal.pone.0078582","volume":"8","author":"V Augis","year":"2013","unstructured":"Augis V, Airiau K, Josselin M, Turcq B, Mahon FX, Belloc F (2013) A single nucleotide polymorphism in cBIM is associated with a slower achievement of major molecular response in chronic myeloid leukaemia treated with imatinib. PLoS One 8:e78582. doi: 10.1371\/journal.pone.0078582","journal-title":"PLoS One"},{"key":"520_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrg1272","volume":"5","author":"AL Barabasi","year":"2004","unstructured":"Barabasi AL, Oltvai ZN (2004) Network biology: understanding the cell\u2019s functional organization. Nat Rev Genet 5:101\u2013113. doi: 10.1038\/nrg1272","journal-title":"Nat Rev Genet"},{"key":"520_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1261\/rna.7240905","volume":"11","author":"S Baskerville","year":"2005","unstructured":"Baskerville S, Bartel DP (2005) Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 11:241\u2013247. doi: 10.1261\/rna.7240905","journal-title":"RNA"},{"key":"520_CR6","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10142-015-0451-2","volume":"15","author":"H Budak","year":"2015","unstructured":"Budak H, Akpinar BA (2015) Plant miRNAs: biogenesis, organization and origins. Funct Integr Genomics 15:523\u2013531. doi: 10.1007\/s10142-015-0451-2","journal-title":"Funct Integr Genomics"},{"key":"520_CR7","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.bbrc.2010.05.037","volume":"396","author":"G Cao","year":"2010","unstructured":"Cao G, Huang B, Liu Z, Zhang J, Xu H, Xia W, Li J, Li S, Chen L, Ding H, Zhao Q, Fan M, Shen B, Shao N (2010) Intronic miR-301 feedback regulates its host gene, ska2, in A549 cells by targeting MEOX2 to affect ERK\/CREB pathways. Biochem Biophys Res Commun 396:978\u2013982. doi: 10.1016\/j.bbrc.2010.05.037","journal-title":"Biochem Biophys Res Commun"},{"key":"520_CR8","doi-asserted-by":"publisher","first-page":"W432","DOI":"10.1093\/nar\/gki441","volume":"33","author":"DS Chekmenev","year":"2005","unstructured":"Chekmenev DS, Haid C, Kel AE (2005) P-Match: transcription factor binding site search by combining patterns and weight matrices. Nucleic Acids Res 33:W432\u2013W437. doi: 10.1093\/nar\/gki441","journal-title":"Nucleic Acids Res"},{"key":"520_CR9","doi-asserted-by":"publisher","first-page":"D239","DOI":"10.1093\/nar\/gkv1258","volume":"44","author":"CH Chou","year":"2016","unstructured":"Chou CH, Chang NW, Shrestha S, Hsu SD, Lin YL, Lee WH, Yang CD, Hong HC, Wei TY, Tu SJ, Tsai TR, Ho SY, Jian TY, Wu HY, Chen PR, Lin NC, Huang HT, Yang TL, Pai CY, Tai CS, Chen WL, Huang CY, Liu CC, Weng SL, Liao KW, Hsu WL, Huang HD (2016) miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database. Nucleic Acids Res 44:D239\u2013D247. doi: 10.1093\/nar\/gkv1258","journal-title":"Nucleic Acids Res"},{"key":"520_CR10","doi-asserted-by":"publisher","first-page":"D662","DOI":"10.1093\/nar\/gku1010","volume":"43","author":"F Cunningham","year":"2015","unstructured":"Cunningham F, Amode MR, Barrell D, Beal K, Billis K, Brent S, Carvalho-Silva D, Clapham P, Coates G, Fitzgerald S, Gil L, Giron CG, Gordon L, Hourlier T, Hunt SE, Janacek SH, Johnson N, Juettemann T, Kahari AK, Keenan S, Martin FJ, Maurel T, McLaren W, Murphy DN, Nag R, Overduin B, Parker A, Patricio M, Perry E, Pignatelli M, Riat HS, Sheppard D, Taylor K, Thormann A, Vullo A, Wilder SP, Zadissa A, Aken BL, Birney E, Harrow J, Kinsella R, Muffato M, Ruffier M, Searle SM, Spudich G, Trevanion SJ, Yates A, Zerbino DR, Flicek P (2015) Ensembl 2015. Nucleic Acids Res 43:D662\u2013D669. doi: 10.1093\/nar\/gku1010","journal-title":"Nucleic Acids Res"},{"key":"520_CR11","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.semcancer.2006.07.014","volume":"16","author":"CV Dang","year":"2006","unstructured":"Dang CV, O\u2019Donnell KA, Zeller KI, Nguyen T, Osthus RC, Li F (2006) The c-Myc target gene network. Semin Cancer Biol 16:253\u2013264. doi: 10.1016\/j.semcancer.2006.07.014","journal-title":"Semin Cancer Biol"},{"key":"520_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1179\/1607845413Y.0000000102","volume":"19","author":"DM Elghannam","year":"2014","unstructured":"Elghannam DM, Ibrahim L, Ebrahim MA, Azmy E, Hakem H (2014) Association of MDR1 gene polymorphism (G2677T) with imatinib response in Egyptian chronic myeloid leukemia patients. Hematology 19:123\u2013128. doi: 10.1179\/1607845413Y.0000000102","journal-title":"Hematology"},{"key":"520_CR13","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.1182\/blood-2011-03-341073","volume":"118","author":"N Esposito","year":"2011","unstructured":"Esposito N, Colavita I, Quintarelli C, Sica AR, Peluso AL, Luciano L, Picardi M, Del Vecchio L, Buonomo T, Hughes TP, White D, Radich JP, Russo D, Branford S, Saglio G, Melo JV, Martinelli R, Ruoppolo M, Kalebic T, Martinelli G, Pane F (2011) SHP-1 expression accounts for resistance to imatinib treatment in Philadelphia chromosome-positive cells derived from patients with chronic myeloid leukemia. Blood 118:3634\u20133644. doi: 10.1182\/blood-2011-03-341073","journal-title":"Blood"},{"key":"520_CR14","doi-asserted-by":"publisher","first-page":"5150","DOI":"10.1038\/srep05150","volume":"4","author":"Z Guo","year":"2014","unstructured":"Guo Z, Maki M, Ding R, Yang Y, Zhang B, Xiong L (2014) Genome-wide survey of tissue-specific microRNA and transcription factor regulatory networks in 12 tissues. Sci Rep 4:5150. doi: 10.1038\/srep05150","journal-title":"Sci Rep"},{"key":"520_CR15","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1126\/science.1151651","volume":"319","author":"O Hobert","year":"2008","unstructured":"Hobert O (2008) Gene regulation by transcription factors and microRNAs. Science 319:1785\u20131786. doi: 10.1126\/science.1151651","journal-title":"Science"},{"key":"520_CR16","doi-asserted-by":"publisher","first-page":"D163","DOI":"10.1093\/nar\/gkq1107","volume":"39","author":"SD Hsu","year":"2011","unstructured":"Hsu SD, Lin FM, Wu WY, Liang C, Huang WC, Chan WL, Tsai WT, Chen GZ, Lee CJ, Chiu CM, Chien CH, Wu MC, Huang CY, Tsou AP, Huang HD (2011) miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res 39:D163\u2013D169. doi: 10.1093\/nar\/gkq1107","journal-title":"Nucleic Acids Res"},{"key":"520_CR17","doi-asserted-by":"publisher","first-page":"e22110","DOI":"10.1371\/journal.pone.0022110","volume":"6","author":"J Jelinek","year":"2011","unstructured":"Jelinek J, Gharibyan V, Estecio MR, Kondo K, He R, Chung W, Lu Y, Zhang N, Liang S, Kantarjian HM, Cortes JE, Issa JP (2011) Aberrant DNA methylation is associated with disease progression, resistance to imatinib and shortened survival in chronic myelogenous leukemia. PLoS One 6:e22110. doi: 10.1371\/journal.pone.0022110","journal-title":"PLoS One"},{"key":"520_CR18","doi-asserted-by":"publisher","first-page":"D98","DOI":"10.1093\/nar\/gkn714","volume":"37","author":"Q Jiang","year":"2009","unstructured":"Jiang Q, Wang Y, Hao Y, Juan L, Teng M, Zhang X, Li M, Wang G, Liu Y (2009) miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Res 37:D98\u2013D104. doi: 10.1093\/nar\/gkn714","journal-title":"Nucleic Acids Res"},{"key":"520_CR19","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1093\/annonc\/mdp452","volume":"21","author":"DH Kim","year":"2010","unstructured":"Kim DH, Xu W, Kamel-Reid S, Liu X, Jung CW, Kim S, Lipton JH (2010) Clinical relevance of vascular endothelial growth factor (VEGFA) and VEGF receptor (VEGFR2) gene polymorphism on the treatment outcome following imatinib therapy. Ann Oncol 21:1179\u20131188. doi: 10.1093\/annonc\/mdp452","journal-title":"Ann Oncol"},{"key":"520_CR20","doi-asserted-by":"publisher","first-page":"D152","DOI":"10.1093\/nar\/gkq1027","volume":"39","author":"A Kozomara","year":"2011","unstructured":"Kozomara A, Griffiths-Jones S (2011) miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 39:D152\u2013D157. doi: 10.1093\/nar\/gkq1027","journal-title":"Nucleic Acids Res"},{"key":"520_CR21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.18632\/oncoscience.2","volume":"1","author":"H Li","year":"2014","unstructured":"Li H, Yang BB (2014) MicroRNA-in drug resistance. Oncoscience 1:3\u20134","journal-title":"Oncoscience"},{"key":"520_CR22","doi-asserted-by":"publisher","first-page":"e59532","DOI":"10.1371\/journal.pone.0059532","volume":"8","author":"S Lin","year":"2013","unstructured":"Lin S, Pan L, Guo S, Wu J, Jin L, Wang JC, Wang S (2013) Prognostic role of microRNA-181a\/b in hematological malignancies: a meta-analysis. PLoS One 8:e59532. doi: 10.1371\/journal.pone.0059532","journal-title":"PLoS One"},{"key":"520_CR23","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.bbrc.2012.07.098","volume":"425","author":"L Liu","year":"2012","unstructured":"Liu L, Wang S, Chen R, Wu Y, Zhang B, Huang S, Zhang J, Xiao F, Wang M, Liang Y (2012) Myc induced miR-144\/451 contributes to the acquired imatinib resistance in chronic myelogenous leukemia cell K562. Biochem Biophys Res Commun 425:368\u2013373. doi: 10.1016\/j.bbrc.2012.07.098","journal-title":"Biochem Biophys Res Commun"},{"key":"520_CR24","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/ijc.24294","volume":"125","author":"N Lounnas","year":"2009","unstructured":"Lounnas N, Frelin C, Gonthier N, Colosetti P, Sirvent A, Cassuto JP, Berthier F, Sirvent N, Rousselot P, Dreano M, Peyron JF, Imbert V (2009) NF-kappaB inhibition triggers death of imatinib-sensitive and imatinib-resistant chronic myeloid leukemia cells including T315I Bcr-Abl mutants. Int J Cancer 125:308\u2013317. doi: 10.1002\/ijc.24294","journal-title":"Int J Cancer"},{"key":"520_CR25","doi-asserted-by":"publisher","first-page":"e3420","DOI":"10.1371\/journal.pone.0003420","volume":"3","author":"M Lu","year":"2008","unstructured":"Lu M, Zhang Q, Deng M, Miao J, Guo Y, Gao W, Cui Q (2008) An analysis of human microRNA and disease associations. PLoS One 3:e3420. doi: 10.1371\/journal.pone.0003420","journal-title":"PLoS One"},{"key":"520_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1476-4598-10-41","volume":"10","author":"K Machova Polakova","year":"2011","unstructured":"Machova Polakova K, Lopotova T, Klamova H, Burda P, Trneny M, Stopka T, Moravcova J (2011) Expression patterns of microRNAs associated with CML phases and their disease related targets. Mol Cancer 10:41. doi: 10.1186\/1476-4598-10-41","journal-title":"Mol Cancer"},{"key":"520_CR27","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/bies.200800212","volume":"31","author":"NJ Martinez","year":"2009","unstructured":"Martinez NJ, Walhout AJ (2009) The interplay between transcription factors and microRNAs in genome-scale regulatory networks. Bioessays 31:435\u2013445. doi: 10.1002\/bies.200800212","journal-title":"Bioessays"},{"key":"520_CR28","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4161\/cc.2.4.428","volume":"2","author":"I Matsumura","year":"2003","unstructured":"Matsumura I, Tanaka H, Kanakura Y (2003) E2F1 and c-Myc in cell growth and death. Cell Cycle 2:333\u2013338","journal-title":"Cell Cycle"},{"key":"520_CR29","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.7314\/APJCP.2014.15.4.1863","volume":"15","author":"ZS Mohamad Ashari","year":"2014","unstructured":"Mohamad Ashari ZS, Sulong S, Hassan R, Husin A, Sim GA, Abdul Wahid SF (2014) Low level of TERC gene amplification between chronic myeloid leukaemia patients resistant and respond to imatinib mesylate treatment. Asian Pac J Cancer Prev 15:1863\u20131869","journal-title":"Asian Pac J Cancer Prev"},{"key":"520_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1755-8166-6-27","volume":"6","author":"N Mosakhani","year":"2013","unstructured":"Mosakhani N, Mustjoki S, Knuutila S (2013) Down-regulation of miR-181c in imatinib-resistant chronic myeloid leukemia. Mol Cytogenet 6:27. doi: 10.1186\/1755-8166-6-27","journal-title":"Mol Cytogenet"},{"key":"520_CR31","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1158\/1541-7786.MCR-10-0510","volume":"9","author":"A Porro","year":"2011","unstructured":"Porro A, Iraci N, Soverini S, Diolaiti D, Gherardi S, Terragna C, Durante S, Valli E, Kalebic T, Bernardoni R, Perrod C, Haber M, Norris MD, Baccarani M, Martinelli G, Perini G (2011) c-MYC oncoprotein dictates transcriptional profiles of ATP-binding cassette transporter genes in chronic myelogenous leukemia CD34+ hematopoietic progenitor cells. Mol Cancer Res 9:1054\u20131066. doi: 10.1158\/1541-7786.MCR-10-0510","journal-title":"Mol Cancer Res"},{"key":"520_CR32","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/978-1-61779-427-8_17","volume":"822","author":"A Ruepp","year":"2012","unstructured":"Ruepp A, Kowarsch A, Theis F (2012) PhenomiR: microRNAs in human diseases and biological processes. Methods Mol Biol 822:249\u2013260. doi: 10.1007\/978-1-61779-427-8_17","journal-title":"Methods Mol Biol"},{"key":"520_CR33","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1016\/j.ejca.2009.04.005Schoch","volume":"45","author":"E San Jose-Eneriz","year":"2009","unstructured":"San Jose-Eneriz E, Agirre X, Jimenez-Velasco A, Cordeu L, Martin V, Arqueros V, Garate L, Fresquet V, Cervantes F, Martinez-Climent JA, Heiniger A, Torres A, Prosper F, Roman-Gomez J (2009) Epigenetic down-regulation of BIM expression is associated with reduced optimal responses to imatinib treatment in chronic myeloid leukaemia. Eur J Cancer 45:1877\u20131889. doi: 10.1016\/j.ejca.2009.04.005Schoch","journal-title":"Eur J Cancer"},{"key":"520_CR34","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/sj.leu.2402813","volume":"17","author":"C Schoch","year":"2003","unstructured":"Schoch C, Haferlach T, Kern W, Schnittger S, Berger U, Hehlmann R, Hiddemann W, Hochhaus A (2003) Occurrence of additional chromosome aberrations in chronic myeloid leukemia patients treated with imatinib mesylate. Leukemia 17:461\u2013463. doi: 10.1038\/sj.leu.2402813","journal-title":"Leukemia"},{"key":"520_CR35","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.7314\/APJCP.2013.14.4.2447","volume":"14","author":"QC Sun","year":"2013","unstructured":"Sun QC, Liu MB, Shen HJ, Jiang Z, Xu L, Gao LP, Ni JL, Wu SL (2013) Inhibition by imatinib of expression of O-glycan-related glycosyltransferases and tumor-associated carbohydrate antigens in the K562 human leukemia cell line. Asian Pac J Cancer Prev 14:2447\u20132451","journal-title":"Asian Pac J Cancer Prev"},{"key":"520_CR36","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.1182\/blood-2006-09-045104","volume":"109","author":"L Venturini","year":"2007","unstructured":"Venturini L, Battmer K, Castoldi M, Schultheis B, Hochhaus A, Muckenthaler MU, Ganser A, Eder M, Scherr M (2007) Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells. Blood 109:4399\u20134405. doi: 10.1182\/blood-2006-09-045104","journal-title":"Blood"},{"key":"520_CR37","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1158\/0008-5472.CAN-11-0068","volume":"71","author":"A Virgili","year":"2011","unstructured":"Virgili A, Koptyra M, Dasgupta Y, Glodkowska-Mrowka E, Stoklosa T, Nacheva EP, Skorski T (2011) Imatinib sensitivity in BCR-ABL1-positive chronic myeloid leukemia cells is regulated by the remaining normal ABL1 allele. Cancer Res 71:5381\u20135386. doi: 10.1158\/0008-5472.CAN-11-0068","journal-title":"Cancer Res"},{"key":"520_CR38","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.semcancer.2006.07.015","volume":"16","author":"M Vita","year":"2006","unstructured":"Vita M, Henriksson M (2006) The Myc oncoprotein as a therapeutic target for human cancer. Semin Cancer Biol 16:318\u2013330. doi: 10.1016\/j.semcancer.2006.07.015","journal-title":"Semin Cancer Biol"},{"key":"520_CR39","doi-asserted-by":"publisher","first-page":"D119","DOI":"10.1093\/nar\/gkp803","volume":"38","author":"J Wang","year":"2010","unstructured":"Wang J, Lu M, Qiu C, Cui Q (2010) TransmiR: a transcription factor-microRNA regulation database. Nucleic Acids Res 38:D119\u2013D122. doi: 10.1093\/nar\/gkp803","journal-title":"Nucleic Acids Res"},{"key":"520_CR40","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nrc2126","volume":"7","author":"E Weisberg","year":"2007","unstructured":"Weisberg E, Manley PW, Cowan-Jacob SW, Hochhaus A, Griffin JD (2007) Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia. Nat Rev Cancer 7:345\u2013356. doi: 10.1038\/nrc2126","journal-title":"Nat Rev Cancer"},{"key":"520_CR41","doi-asserted-by":"publisher","first-page":"D105","DOI":"10.1093\/nar\/gkn851","volume":"37","author":"F Xiao","year":"2009","unstructured":"Xiao F, Zuo Z, Cai G, Kang S, Gao X, Li T (2009) miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res 37:D105\u2013D110. doi: 10.1093\/nar\/gkn851","journal-title":"Nucleic Acids Res"},{"key":"520_CR42","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/bioinformatics\/btp618","volume":"26","author":"W Yu","year":"2010","unstructured":"Yu W, Clyne M, Khoury MJ, Gwinn M (2010) Phenopedia and Genopedia: disease-centered and gene-centered views of the evolving knowledge of human genetic associations. Bioinformatics 26:145\u2013146. doi: 10.1093\/bioinformatics\/btp618","journal-title":"Bioinformatics"},{"key":"520_CR43","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s10142-014-0411-2","volume":"15","author":"P Zhao","year":"2015","unstructured":"Zhao P, Ding D, Zhang F, Zhao X, Xue Y, Li W, Fu Z, Li H, Tang J (2015) Investigating the molecular genetic basis of heterosis for internode expansion in maize by microRNA transcriptomic deep sequencing. Funct Integr Genomics 15:261\u2013270. doi: 10.1007\/s10142-014-0411-2","journal-title":"Funct Integr Genomics"},{"key":"520_CR44","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/ijc.24782","volume":"126","author":"T Zheng","year":"2010","unstructured":"Zheng T, Wang J, Chen X, Liu L (2010) Role of microRNA in anticancer drug resistance. Int J Cancer 126:2\u201310. doi: 10.1002\/ijc.24782","journal-title":"Int J Cancer"}],"container-title":["Functional & Integrative Genomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-016-0520-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10142-016-0520-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-016-0520-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T02:14:44Z","timestamp":1601086484000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10142-016-0520-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,16]]},"references-count":44,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["520"],"URL":"https:\/\/doi.org\/10.1007\/s10142-016-0520-1","relation":{},"ISSN":["1438-793X","1438-7948"],"issn-type":[{"value":"1438-793X","type":"print"},{"value":"1438-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,16]]}}}